Introduction. The contribution of hyperreflexia to impairment after stroke is debated. Spinal motoneuron excitability in healthy subjects and stroke patients with and without spasticity was compared. Methods. Twenty-four patients with single stroke more than 6 months ago and 18 gender-matched healthy volunteers were included. Spasticity was assessed according to the Modified Ashworth Scale. Mmax amplitude and F wave frequency in the abductor pollicis brevis muscle were measured by electrical stimulation of the median nerve. Results. Mmax values were comparable between the groups. However, patients with (n = 7) and without (n = 17) clinically evident spasticity had a significant increase in F wave frequency when compared with healthy subjects. F wave frequency did not differ between spastic and nonspastic patients. Discussion. Increase in spinal motoneuron excitability after stroke is present in stroke patients with minor or no motor deficiencies and does not necessarily lead to spasticity.
S troke results in negative symptoms such as diminished muscle strength and coordination. Positive symptoms such as spasticity are thought to contribute to impairment, and interventions to reduce spasticity are often used. As Dietz and Sinkjaer 1 recently stated, "the dominant view is that treatment of spasticity should be directed towards a reduction of stretch reflex activity." As the authors note, however, the extent to which hyperreflexia contributes to the impairment after acquired brain injury is debatable. According to the definition proposed by Lance, 2 spasticity is defined in part by "a velocitydependent increase in tonic stretch reflexes (muscle tone)." Hence, one would expect increased motoneuron excitability in patients with clinical spasticity. However, as measured by the H-reflex, this increase is not always present in spastic patients, 3 and neurophysiologic evidence of hyperreflexia is not a necessary factor in the development of spasticity.
To further examine the relationship between spasticity and changes in spinal excitability, we set out to explore whether neurophysiologic evidence of increased spinal excitability is sufficient to elicit clinical spasticity. Spinal motoneuron excitability in a group of stroke patients with minor initial motor deficits was compared with that of healthy subjects. Excitability was measured by the F wave technique in which electrical stimulation of a motor nerve causes a recurrent discharge of antidromically activated motoneurons. Although the mechanisms are complicated, 4 the probability of a recurrent discharge depends on the motoneuron excitability. In the abductor pollicis brevis muscle (APB), F wave frequency and amplitude is higher when excitability is increased by a conditioning transcranial magnetic stimulation. 5 Conversely, the anesthetic agent Propofol decreases F wave frequency, most likely because of a decrease in excitability. 6 Compared with H-reflex measures, F wave frequencies are more sensitive to changes in excitability after interventions reducing spasticity. 7 Moreover, the technique is easier to use and thus is less sensitive to variations in experimental setup.
Materials and Methods
A review of medical charts identified 24 stroke patients for participation in the study (16 males, mean age 57 years). Inclusion criteria were first clinical stroke more than 6 months ago, Medical Research Council (MRC) score of 3 or 4 at admission to acute stroke unit, no prior neurological diseases, and age ≥18 years. The study also included a control group of 18 gender-matched healthy volunteers (9 males, mean age 60 years). Stroke location was determined by affected side and whether the lesion included cortex or only subcortical structures (see Table 1 for patient characteristics). All participants gave written informed consent to participate in the study. The regional ethical committee reviewed and approved the study, and the experiment was conducted according to the standards set by the Declaration of Helsinki.
Electromyography (EMG) activity was measured in APB by surface electrodes in a belly tendon montage and recorded and stored on a VikingSelect (Viasys Healthcare, Conshohocken, PA). A bipolar electrical stimulator was used with the cathode placed distally. Mmax and F waves were measured. The median nerve was stimulated electrically (1 Hz) at the wrist. The size of the M wave was measured peak to peak. F waves were defined as potentials with amplitude of at least 20 µV. 8 The F wave frequency was defined as the number of traces with 1 or more F waves in the 20 traces obtained. 8 Among the patient group, deficits were measured with the action research arm test (ARAT). 9 The test measures included grasp, grip, pinch, and gross movement. Combined scores totaled 0 to 57, with 57 indicating no measurable deficit. Spasticity was assessed by the Modified Ashworth Scale (MAS) 10 in the upper extremity. Physiotherapists evaluated patients to determine all the aforementioned scores. The physician conducting the EMG examinations was unaware of the results until after the analysis of EMG data. In addition, a physician assessed muscle strength in the APB according to the MRC scale.
Analyses compared Mmax and F wave measures among patients and healthy participants. Second, the consequence of injury location was explored. The t test was applied to normally distributed Mmax values; nonparametric statistics, that is, Wilcoxon rank-sum tests, were applied to F wave frequencies, where normal distribution could not be achieved. A level of significance of P < .05 was used. Normally distributed data are presented with a mean and standard deviation, whereas median and range are included for data analyzed with nonparametric statistics.
Results
Participating patients had minor or no motor deficits, as reflected by a median ARAT score of 57 (range, 16-57) and MRC scores of 4 to 5 in ABP. Seventeen of the 24 patients had no clinically evident spasticity (MAS 0), whereas the remaining 7 patients had slight to more marked increase in muscle tone (MAS 1-2), see Table 1 .
Mmax values were comparable between the groups: 14.4 mV (4.4) in stroke patients and 14.2 mV (4.2) in healthy subjects (P = .85). F wave frequencies were significantly higher among stroke patients (19 [7-20]) compared with healthy subjects (16 [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] ; P = .006).
To explore the contribution of clinical spasticity to the increase in F wave frequency, patients were divided into 2 groups, one group without clinical spasticity (MAS = 0) and another with slight or more marked increase in muscle tone (MAS 1-2). The 2 groups of stroke patients and the group of healthy subjects were compared by nonparametric 1-way analyses of variance (Kruskal-Wallis test). This showed a significant difference between the groups (P = .015). A subsequent comparison of the groups showed a significant increase in F wave frequency in both patient groups compared with healthy subjects (both P < .05); however, there was no significant difference between the 2 groups of patients (P = .23), see 
Discussion
We found increased F wave frequencies in a group of less impaired stroke patients with and without clinically evident spasticity. Most likely, this reflects an increase in spinal motoneuron excitability. However, recurrent discharge of motoneurons depends on dendritic spikes reactivating the soma. 4 Thus, changes in dendritic morphology could potentially cause similar changes. In the group of normal subjects, F wave frequency was similar to what has been reported previously. 8 Traditionally, clinical evaluation of spasticity following acquired brain injury has focused on the velocity-dependent increase in resistance, 2 but lately more attention has been paid to dystonic, hypertonia, and intrinsic changes in muscles. Nevertheless, decreases in spinal excitability are often interpreted as successful antispastic treatment. 11 Clinically evident spasticity is not always accompanied by an increase in spinal reflexes, 12 and as our results show, an increase in spinal motoneuron excitability does not necessarily lead to spasticity. The majority of the patients studied had no measurable deficits in either muscle strength or hand function, despite increased spinal excitability. Thus, we can only agree that pharmacological interventions aimed at reducing spasticity should not focus on measures of spinal excitability alone 13 but rather on functional outcome.
Figure 1 F Wave Frequency in Relation to Clinical Spasticity
Note: Solid lines indicate median values, boxes 25th to 75th percentile, and whisker 10th and 90th percentile of F wave frequency. Black points represent single subject outliers.
